CEO Total Pay
$16.3M
FY2025 Summary Compensation, well above median
The CEO earned $16.3M in FY2025 against median worker pay of $58,663 · Measuring Instruments.
Data updated August 2026
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $58,663. Industry placement uses the FY2025 SIC-38 peer cohort (# 11 of 86, 88th percentile - top quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Measuring Instruments companies.
Dexcom Inc CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$16,308,314 Top 18% higher than 82% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($16.3M) against pay ratio (278:1) for Dexcom Inc (marked) and its 5 closest same-industry peers, against the Measuring Instruments industry median on both axes.
Exclusive CEO-to-median-worker bands across 80 complete latest-FY filings in SIC 38. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Dexcom Inc's structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2022 | $15.4M | - | $65,706 | 235:1 | - |
| 2023 | $15.7M | +1.8% | $85,574 | 184:1 | -51:1 |
| 2024 | $114K | -99% | $114,213 | 139:1 | -45:1 |
| 2025 | $16.3M | +14179% | $58,663 | 278:1 | +139:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1093557, FY2022–2025. Adjacent-year deltas only.
Dexcom Inc's FY2025 ratio 278:1 ranks #11 of 86 Measuring Instruments filers (88th percentile). the CEO earned 278× the median employee ($58,663) in FY2025.
Median employee $58,663 (PAR-MED); STEEP · PEAK stamps put about 278 median-wage years per CEO year.
CEO Total Pay
$16.3M
FY2025 Summary Compensation, well above median
Pay Ratio
278:1
Elevated vs. peers
Dexcom Inc's FY2025 ratio 278:1 ranks #11 of 86 Measuring Instruments filers (88th percentile). The structured pay-ratio disclosure reports the total without line-item components. Measuring Instruments (SIC 38) median ratio is 121:1 across 86 FY2025 filers; Dexcom Inc's $16.3M CEO total is above the $8.0M industry median CEO pay.
Dollar rank #252 and ratio rank #216 split - treat 278:1 as a disclosure, not a fairness score. Open Measuring Instruments peers.
Read our methodology - how this data is sourced, computed, and verified. Dexcom Inc's FY2025 ratio 278:1 ranks #11 of 86 Measuring Instruments filers (88th percentile).
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $16.3M (Δ $20K lighter vs Dexcom Inc); MID · HIGH-MED vs this page's STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $16.3M (Δ $21K heavier vs Dexcom Inc); EXTREME · LOW-MED vs this page's STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $16.3M (Δ $40K lighter vs Dexcom Inc); MID · ELITE-MED vs this page's STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $16.4M (Δ $67K heavier vs Dexcom Inc); MODEST · ELITE-MED vs this page's STEEP · PEAK · PAR-MED.
Stryker Corp stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Dexcom Inc's STEEP filing.
Dexcom Inc's FY2025 package sits #252 by CEO dollars and #216 by ratio under PEAK · STEEP.
Dexcom Inc's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.